Tuesday, November 01, 2011 12:02:36 PM
This entire exchange started with your assertion that the value of the CPRX warrants was only $.30, while I suggested these were closer to $.77.
Since you've questioned the appropriateness of my Black Scholes assumptions, why don't you provide your own to clarify the issue.
Since you've questioned the appropriateness of my Black Scholes assumptions, why don't you provide your own to clarify the issue.
Recent CPRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 09:23:18 PM
- Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance • GlobeNewswire Inc. • 02/25/2026 09:07:55 PM
- Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference • GlobeNewswire Inc. • 02/24/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 10:04:15 PM
- Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:03:17 PM
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies • GlobeNewswire Inc. • 01/08/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:30 PM
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) • GlobeNewswire Inc. • 01/05/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:15 PM
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/15/2025 01:03:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/12/2025 09:25:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2025 10:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/26/2025 06:54:26 PM
